These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3987795)

  • 1. Maximal aerobic power and blood pressure in normotensive subjects after acute and chronic administration of metoprolol.
    van Baak M; Jennen W; Verstappen FT
    Eur J Clin Pharmacol; 1985; 28(2):143-8. PubMed ID: 3987795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute and chronic metoprolol administration during submaximal and maximal exercise.
    van Baak MA; Jennen W; Muijtjens A; Verstappen FT
    Int J Sports Med; 1985 Dec; 6(6):347-52. PubMed ID: 4077364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol.
    Folgering H; van Bussel M
    Eur J Clin Pharmacol; 1980 Oct; 18(3):225-9. PubMed ID: 7439241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological effects of concomitant administration of beta-adrenoceptor blocker and agonist in normal subjects: characterization by heart rate response to exercise. Effects of beta-blocker combined with beta-agonist.
    Karita M; Sato H; Koretsune Y; Imai K; Ozaki H; Yokoyama H; Hori M; Takeda H; Inoue M; Kamada T
    Eur J Clin Pharmacol; 1995; 48(6):467-71. PubMed ID: 8582465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of controlled-release metoprolol on blood pressure and exercise heart rate in hypertension: a comparison with conventional tablets.
    Rydén L; Kristensson BE; Westergren G
    Eur J Clin Pharmacol; 1988; 33 Suppl():S33-7. PubMed ID: 3371392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy.
    Currie PJ; Kelly MJ; McKenzie A; Harper RW; Lim YL; Federman J; Anderson ST; Pitt A
    J Am Coll Cardiol; 1984 Jan; 3(1):203-9. PubMed ID: 6140277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers.
    van Steveninck AL; Pieters MS; Schoemaker HC; Breimer DD; Cohen AF
    Br J Clin Pharmacol; 1993 Feb; 35(2):114-20. PubMed ID: 8443028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men.
    Sklar J; Johnston GD; Overlie P; Gerber JG; Brammell HL; Gal J; Nies AS
    Circulation; 1982 May; 65(5):894-9. PubMed ID: 7074750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo controlled comparison of the effects of metoprolol and celiprolol on echo-Doppler measurements of cardiovascular function in normal volunteers.
    Silke B; Thompson A; Leitch A; Riddell JG
    Br J Clin Pharmacol; 1995 Jul; 40(1):37-42. PubMed ID: 8527266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentration-effect relationship of metoprolol during and after pregnancy.
    Högstedt S; Rane A
    Eur J Clin Pharmacol; 1993; 44(3):243-6. PubMed ID: 8491238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
    Uusitalo AJ; Keyriläinen O
    Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation.
    Oosterhuis B; Jonkman JH; Kerkhof FA
    Eur J Clin Pharmacol; 1988; 33 Suppl():S15-8. PubMed ID: 3371389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect blood pressure and heart rate measured quickly without observer bias using a semi-automatic machine (auto-manometer)--response to isometric exercise in normal healthy males and its modification by beta-adrenoceptor blockade.
    Nyberg G
    Br J Clin Pharmacol; 1977 Jun; 4(3):275-81. PubMed ID: 901695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exercise performance after long-term administration of enalapril or metoprolol. A randomized double-blind study of hypertensive leisure-time sportsmen].
    Teixeira A; Billigmann PW; Bohner H; Schumacher H
    Dtsch Med Wochenschr; 1992 Jun; 117(25):967-73. PubMed ID: 1611965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative beta-adrenoceptor blocking effects of penbutolol, atenolol and sustained-release metoprolol in healthy volunteers.
    Mucklow JC; Kuhn S
    Eur J Clin Pharmacol; 1984; 27(3):269-73. PubMed ID: 6510453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of acute or chronic ingestion of propranolol or metoprolol on the physiological responses to prolonged, submaximal exercise in hypertensive men.
    Wilcox RG; Bennett T; Macdonald IA; Herbert M; Skene AM
    Br J Clin Pharmacol; 1984 Mar; 17(3):273-81. PubMed ID: 6712861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective and nonselective beta-blockade of the peripheral circulation.
    Hiatt WR; Fradl DC; Zerbe GO; Byyny RL; Nies AS
    Clin Pharmacol Ther; 1984 Jan; 35(1):12-8. PubMed ID: 6690167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional capacity in healthy volunteers before and following beta-blockade with controlled-release metoprolol.
    Rønnevik PK; Nordrehaug JE; von der Lippe G
    Eur J Clin Pharmacol; 1995; 48(2):127-31. PubMed ID: 7589026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing beta-blocking effects of carvedilol and metoprolol.
    Stoschitzky K; Koshucharova G; Zweiker R; Maier R; Watzinger N; Fruhwald FM; Klein W
    Eur J Heart Fail; 2001 Jun; 3(3):343-9. PubMed ID: 11378006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
    Liu J; Liu ZQ; Tan ZR; Chen XP; Wang LS; Zhou G; Zhou HH
    Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.